论文部分内容阅读
目的 :探讨葛根素注射液治疗下肢深静脉血栓后综合征的临床疗效。方法 :用随机法将 68例下肢深静脉血栓后综合征患者分为葛根素组 ( 3 8例 )和对照组 ( 3 0例 ) ,在常规中药治疗的同时 ,前者给予葛根素 4 0 0~ 60 0mg静滴 ,后者给予复方丹参注射液静滴 ,治疗前后观察患者症状、体征及相关理化检查等指标的变化。 结果 :葛根素注射液可明显缓解下肢深静脉血栓后综合征患者的肢体肿胀、疼痛等症状 ,改善下肢静脉的血液循环 ,对患者血液的高凝状态也有一定的治疗作用 ;较对照组有更为明显的疗效。结论 :葛根素注射液对于治疗下肢深静脉血栓后综合征有较好的治疗效果 ,是一种有希望的周围血管病治疗用药。
Objective: To investigate the clinical efficacy of puerarin injection in the treatment of post-disease deep venous thrombosis syndrome. Methods: Sixty-eight patients with deep venous thrombosis syndrome were divided into puerarin group (38 cases) and control group (30 cases) by randomization method. The former was given puerarin 400~ 60mg intravenous infusion, the latter given compound Danshen injection intravenous infusion, before and after treatment to observe the patient’s symptoms, physical signs and physical and chemical changes. Results: Puerarin injection can significantly relieve limb swelling, pain and other symptoms of patients with deep venous thrombosis syndrome of the lower extremities, improve the blood circulation of the veins of the lower extremities, and have a certain therapeutic effect on the hypercoagulable state of the patients; it has more effect than the control group. For obvious effects. Conclusion: Puerarin injection has a good therapeutic effect on the treatment of post-disease deep venous thrombosis syndrome. It is a promising therapeutic agent for peripheral vascular disease.